Position in RLAY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$17,394,537
+$10,635,085 QoQ
Shares Held
929,692
+36.9% QoQ
Ownership
0.424%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#46
of 256 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RLAY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Woodline Partners LP holds $4,400,572,274 across 197 Biotechnology names. RLAY ranks #68 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
2,002,863 | $375,096,182 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
1,414,173 | $173,349,326 | |
| 3 | TNGX |
Tango Therapeutics, Inc.
|
4,000,567 | $125,057,724 | |
| 4 | BHVN |
Biohaven Ltd.
|
7,660,280 | $113,984,966 | |
| 5 | COGT |
Cogent Biosciences, Inc.
|
2,603,162 | $100,742,369 | |
| 6 | CYTK |
Cytokinetics Inc
|
1,100,708 | $93,769,314 | |
| 7 | RCUS |
Arcus Biosciences, Inc.
|
3,007,798 | $92,730,412 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
2,500,673 | $88,498,817 |
All Filings in RLAY
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,394,537 | 929,692 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $6,759,452 | 679,342 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $5,745,312 | 679,115 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $5,314,560 | 1,018,115 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $3,522,677 | 1,018,115 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $3,978,629 | 1,518,561 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,140,844 | 276,904 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,960,480 | 276,904 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,783,976 | 273,616 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,265,966 | 273,008 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,752,500 | 250,000 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,102,500 | 250,000 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $3,140,000 | 250,000 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $4,529,250 | 275,000 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $4,955,045 | 331,663 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $7,419,301 | 331,663 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $5,555,355 | 331,663 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $9,926,673 | 331,663 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $7,849,506 | 255,601 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $8,059,099 | 255,601 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $10,558,300 | 288,557 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $8,242,870 | 238,440 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $12,186,015 | 293,215 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $14,984,141 | 351,823 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||